Results for tag: "Primary Immunodeficiency Disease Drug"

The Primary Immunodeficiency Disease Drug market is a subset of the Immune Disorders Drugs market, focusing on drugs used to treat primary immunodeficiency diseases (PIDDs). These drugs are used to replace or supplement the body's natural immune system, which is impaired in PIDDs. Common treatments include immunoglobulin replacement therapy, enzyme replacement therapy, and stem cell transplantation. These drugs are used to treat a wide range of PIDDs, including severe combined immunodeficiency, chronic granulomatous disease, and Wiskott-Aldrich syndrome. The Primary Immunodeficiency Disease Drug market is highly competitive, with many companies offering treatments for PIDDs. Some of the major players in the market include CSL Behring, Grifols, Kedrion, Octapharma, Shire, and Takeda. Show Less Read more